Stock 688553 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Sichuan Huiyu Pharmaceutical Co., Ltd.

Equities

688553

CNE100004ZT4

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
13.96 CNY -0.64% Intraday chart for Sichuan Huiyu Pharmaceutical Co., Ltd. -3.72% -7.73%
May. 15 China Grants Drug Registration for Huiyu Pharma's Two Injectables MT
Apr. 26 Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Grants Drug Registration for Huiyu Pharma's Two Injectables
MT
Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sichuan Huiyu Pharmaceutical Gets Chinese FDA Nod for Methotrexate Anti-Tumor Injection
MT
Tranche Update on Sichuan Huiyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.
CI
Huiyu Pharma Unit Gets Libya's Marketing Approval for Cancer Drug
MT
Huiyu Pharma Gets China Registration Approval for Cancer Drug
MT
US FDA Grants New Drug Application to Huiyu Pharma's Cancer Injection
MT
Sichuan Huiyu Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.
CI
Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sichuan Huiyu Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Three Drugs of Huiyu Pharma's Unit Gets Greenlight to Enter Egyptian Market
MT
Huiyu Pharma's Unit Gets Greenlight to Enter UK Market
MT
Huiyu Pharmaceutical's Subsidiary Administers First Patient for Tumor Drug Trial; Shares Drop 5%
MT
TYK Medicines, Inc. announced that it has received funding from Sichuan Huiyu Pharmaceutical Co., Ltd., CICC Capital Management Co., Ltd., Zhejiang Changxing Financial Holding Group Co., Ltd., and other investors
CI
Huiyu Pharma Passes US FDA Inspection
MT
Chengdu Houhan Technology Co., Ltd. and Beijing Houhong Technology Co., Ltd. agreed to acquire 49.9% stake in Sichuan Huiyu Yueying Pharmaceutical Technology Co., Ltd. from Sichuan Huiyu Pharmaceutical Co., Ltd. for CNY 16.6 million.
CI
Huiyu Pharmaceutical's Methotrexate for Injection Passes Regulatory Evaluation
MT
Sichuan Huiyu Pharma Gets Marketing Approval in Pakistan for Anticancer Drug
MT
Huiyu Pharmaceutical's Fulvestrant Injection Selected for China's Centralized Drug Procurement
MT
Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688553 Stock
  4. News Sichuan Huiyu Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW